Neurobiological Technologies, Inc.

NTII · OTC
Analyze with AI
$0.0001+$0.00 (+0%)
At close:Dec 18, 2025, 9:00 PM UTC
P/E TTM0
P/B TTM0
P/S TTM0
Dividend Yield0%
EPS
Beta-410.838
Valuation
PEG Ratio0.00
FCF Yield-608,105.11%
EV / EBITDA-0.57
Quality
ROIC139.25%
Gross Margin99.50%
Cash Conv. Ratio-0.98
Growth
Revenue 3Y CAGR14.24%
FCF Growth0.00%
Safety
Net Debt / EBITDA-0.57
Interest Coverage0.00
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle-13.83

Neurobiological Technologies, Inc. (NTII) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Neurobiological Technologies, Inc. (NTII) stock price today?

As of Dec 18, 2025, 9:00 PM UTC, Neurobiological Technologies, Inc. (NTII) stock is trading at $0.0001. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date NTII stock quotes for informed trading decisions.

What is Neurobiological Technologies, Inc.'s market capitalization?

Neurobiological Technologies, Inc. (NTII) has a market capitalization of approximately $2.7K. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Neurobiological Technologies, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the NTII stock price changes.

What is the 52-week range for Neurobiological Technologies, Inc. stock?

Neurobiological Technologies, Inc. (NTII) stock has traded in a 52-week range of $0.00 — $0.0001. The 52-week range shows the highest and lowest prices at which NTII traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Neurobiological Technologies, Inc. stock price to this range provides context for recent price action.

How much trading volume does Neurobiological Technologies, Inc. stock have?

Neurobiological Technologies, Inc. (NTII) stock recently traded approximately 1.1K shares. Trading volume indicates market liquidity and investor interest in NTII. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Neurobiological Technologies, Inc. stock.

Does Neurobiological Technologies, Inc. pay dividends to shareholders?

Yes, Neurobiological Technologies, Inc. (NTII) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Neurobiological Technologies, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Neurobiological Technologies, Inc.'s intraday price range?

Today, Neurobiological Technologies, Inc. (NTII) stock has traded in a range of $0.00 — $0.0001. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring NTII's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Neurobiological Technologies, Inc. stock data?

AlphaPilot sources real-time NTII stock quotes, fundamental financial data, and historical price charts for Neurobiological Technologies, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Neurobiological Technologies, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of NTII stock performance.